{"id":3651,"date":"2016-10-20T00:00:00","date_gmt":"2021-03-19T05:22:55","guid":{"rendered":"https:\/\/www.eisai.com.cn\/?p=3651"},"modified":"2021-03-19T13:22:55","modified_gmt":"2021-03-19T05:22:55","slug":"ceo-naito-selected-among-the-best-performing-ceos-in-the-world-by-harvard-business-review","status":"publish","type":"post","link":"https:\/\/www.eisai.com.cn\/en\/2016\/10\/20\/ceo-naito-selected-among-the-best-performing-ceos-in-the-world-by-harvard-business-review\/","title":{"rendered":"CEO Naito Selected among The Best-Performing CEOs in the World by Harvard Business Review"},"content":{"rendered":"
Harvard Business Review has just announced The Best-Performing CEOs in the World, in which CEO Haruo Naito was ranked 87th. Among Japanese companies, only three other CEOs made the list, including Nidec\u2019s Shigenobu Nagamori (42nd), FAST RETAILING\u2019s Tadashi Yanai (46th) and Softbank\u2019s Masayoshi Son (73rd).<\/p>\n
From the pharmaceutical industry, only Novo Nordisk\u2019s Lars Rebien S\u00f8rensen (1st), Biogen\u2019s George Scangos (21st) and Regeneron Pharmaceuticals\u2019 Leonard Schliefer (67th) made the list, making CEO Naito the only one selected from the Japanese pharmaceutical industry.<\/p>\n